Sucrosomial iron is an oral iron preparation developed to treat iron deficiency while reducing the gastrointestinal side effects common to older iron supplements. It consists of ferric pyrophosphate particles coated in phospholipids and a matrix of sucrose esters of fatty acids, a formulation intended to let the iron be absorbed through several pathways in the gut, including between and through intestinal cells and through specialized M-cells, rather than relying solely on the standard iron-absorption route that is limited by the hormone hepcidin. Its gastro-resistant coating is also intended to limit direct irritation of the stomach and intestinal lining, a common cause of poor tolerance of conventional oral iron. It is used as an oral supplement for iron deficiency in a range of clinical settings, including in some patients who cannot tolerate standard ferrous iron salts.
Facts
Classification
ATC ClassSourced to the subject's own accountB: Blood and Blood Forming Organs 1 Route of Administration Sources
1. Anatomical Therapeutic Chemical Classification System (Wikipedia)
WikipediaFirst-level anatomical group codes, Code BQuote, First-level anatomical group codes, Code B
Blood and blood forming organs
View the Source 2. Sucrosomial iron (Wikipedia)
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.